These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
397 related articles for article (PubMed ID: 27874193)
21. Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement. Antonescu CR; Suurmeijer AJ; Zhang L; Sung YS; Jungbluth AA; Travis WD; Al-Ahmadie H; Fletcher CD; Alaggio R Am J Surg Pathol; 2015 Jul; 39(7):957-67. PubMed ID: 25723109 [TBL] [Abstract][Full Text] [Related]
22. Case report: Epithelioid inflammatory myofibroblastic sarcoma treated with an ALK TKI ensartinib. Li M; Xing R; Huang J; Shi C; Wei C; Wang H Front Oncol; 2023; 13():1084456. PubMed ID: 37035183 [TBL] [Abstract][Full Text] [Related]
23. Pulmonary inflammatory myofibroblastic tumor expressing a novel fusion, PPFIBP1-ALK: reappraisal of anti-ALK immunohistochemistry as a tool for novel ALK fusion identification. Takeuchi K; Soda M; Togashi Y; Sugawara E; Hatano S; Asaka R; Okumura S; Nakagawa K; Mano H; Ishikawa Y Clin Cancer Res; 2011 May; 17(10):3341-8. PubMed ID: 21430068 [TBL] [Abstract][Full Text] [Related]
24. Inflammatory myofibroblastic tumor with predominant anaplastic lymphoma kinase-positive cells lacking a myofibroblastic phenotype. Hisaoka M; Shimajiri S; Matsuki Y; Meis-Kindblom JM; Kindblom LG; Li XQ; Wang J; Hashimoto H Pathol Int; 2003 Jun; 53(6):376-81. PubMed ID: 12787312 [TBL] [Abstract][Full Text] [Related]
25. [Clinicopathological features of inflammatory myofibroblastic tumor]. Zhu Y; Ding Y; Song GX; Li X; Ding R; Fan QH; Gong QX Zhonghua Bing Li Xue Za Zhi; 2021 Mar; 50(3):194-200. PubMed ID: 33677881 [No Abstract] [Full Text] [Related]
26. Identification of EML4-ALK as an alternative fusion gene in epithelioid inflammatory myofibroblastic sarcoma. Jiang Q; Tong HX; Hou YY; Zhang Y; Li JL; Zhou YH; Xu J; Wang JY; Lu WQ Orphanet J Rare Dis; 2017 May; 12(1):97. PubMed ID: 28535796 [TBL] [Abstract][Full Text] [Related]
27. FN1: a novel fusion partner of ALK in an inflammatory myofibroblastic tumor. Ouchi K; Miyachi M; Tsuma Y; Tsuchiya K; Iehara T; Konishi E; Yanagisawa A; Hosoi H Pediatr Blood Cancer; 2015 May; 62(5):909-11. PubMed ID: 25682942 [TBL] [Abstract][Full Text] [Related]
28. DCTN1-ALK gene fusion in inflammatory myofibroblastic tumor (IMT) of the CNS. Vidrine DW; Berry JF; Garbuzov A; Falcon C; Tubbs RS; Bui CJ Childs Nerv Syst; 2021 Jul; 37(7):2147-2151. PubMed ID: 34014367 [TBL] [Abstract][Full Text] [Related]
29. ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours. Yamamoto H; Yoshida A; Taguchi K; Kohashi K; Hatanaka Y; Yamashita A; Mori D; Oda Y Histopathology; 2016 Jul; 69(1):72-83. PubMed ID: 26647767 [TBL] [Abstract][Full Text] [Related]
30. Epithelioid inflammatory myofibroblastic sarcoma in abdominal cavity: a case report and review of literature. Wu H; Meng YH; Lu P; Ning HY; Hong L; Kang XL; Duan MG Int J Clin Exp Pathol; 2015; 8(4):4213-9. PubMed ID: 26097614 [TBL] [Abstract][Full Text] [Related]
31. CD30 and ALK combination therapy has high therapeutic potency in RANBP2-ALK-rearranged epithelioid inflammatory myofibroblastic sarcoma. Fordham AM; Xie J; Gifford AJ; Wadham C; Morgan LT; Mould EVA; Fadia M; Zhai L; Massudi H; Ali ZS; Marshall GM; Lukeis RE; Fletcher JI; MacKenzie KL; Trahair TN Br J Cancer; 2020 Sep; 123(7):1101-1113. PubMed ID: 32684628 [TBL] [Abstract][Full Text] [Related]
32. Durable Clinical Response to ALK Tyrosine Kinase Inhibitors in Epithelioid Inflammatory Myofibroblastic Sarcoma Harboring Wang Z; Geng Y; Yuan LY; Wang MM; Ye CY; Sun L; Dai WP; Zang YS Front Oncol; 2022; 12():761558. PubMed ID: 35237506 [TBL] [Abstract][Full Text] [Related]
34. Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor. Cools J; Wlodarska I; Somers R; Mentens N; Pedeutour F; Maes B; De Wolf-Peeters C; Pauwels P; Hagemeijer A; Marynen P Genes Chromosomes Cancer; 2002 Aug; 34(4):354-62. PubMed ID: 12112524 [TBL] [Abstract][Full Text] [Related]
35. Epithelioid Inflammatory Myofibroblastic Sarcoma of the Ovary With RANB2-ALK Fusion: Report of a Case. Fang H; Langstraat CL; Visscher DW; Folpe AL; Schoolmeester JK Int J Gynecol Pathol; 2018 Sep; 37(5):468-472. PubMed ID: 28787324 [TBL] [Abstract][Full Text] [Related]
36. Uterine Inflammatory Myofibroblastic Tumors Frequently Harbor ALK Fusions With IGFBP5 and THBS1. Haimes JD; Stewart CJR; Kudlow BA; Culver BP; Meng B; Koay E; Whitehouse A; Cope N; Lee JC; Ng T; McCluggage WG; Lee CH Am J Surg Pathol; 2017 Jun; 41(6):773-780. PubMed ID: 28490045 [TBL] [Abstract][Full Text] [Related]
37. Uterine Inflammatory Myofibroblastic Tumor Showing an Atypical ALK Signal Pattern by FISH and DES-ALK Fusion by RNA Sequencing: A Case Report. Zarei S; Abdul-Karim FW; Chase DM; Astbury C; Policarpio-Nicolas MLC Int J Gynecol Pathol; 2020 Mar; 39(2):152-156. PubMed ID: 30741845 [TBL] [Abstract][Full Text] [Related]
38. Reclassification of a spindle cell sarcoma after identification of a TFG-ROS1 fusion: A case demonstrating the clinical benefit of next-generation sequencing in sarcoma. Lim JJ; Chen EY; Schaub SK; Wagner MJ Mol Genet Genomic Med; 2024 Apr; 12(4):e2423. PubMed ID: 38622850 [TBL] [Abstract][Full Text] [Related]